ALFACELL: Mushroomed from 18 cents to $9.97, turning $5,000 into $276,944
KERYX: Went from $1.02 to $19.86, turning $5,000 into $97,353
SYMBOLLON: Soared from 5 cents to $5, turning $5,000 into $500,000
INTROBIOTICS: Rocketed from $1.54 to $19.25, turning $5,000 into $62,500
VION: Blasted from 21 cents to $5.50, turning $5,000 into $130,952
I have five recommendations that could deliver even more explosive gains. Join us now and share in the profits.
I guarantee it will change your life because I’m going to show why you don’t have to be a stock market expert to get filthy rich in biotech stocks… how much money you could make in the next six months…and how little you need to get started.
How I Find the Biotech Superstars That Will Hand You Mind-Blowing Profits
The secret to building incredible riches in biotech stocks comes down to one thing: Buying up-and-coming biotech companies on the verge of a major medical breakthrough …
…before Wall Street knows about them…before they get FDA approval…and before their prices skyrocket and all the big money has been made.
That’s what my Profit Lab System does — with near perfect accuracy.
By using advanced computer technologies, I was able to reverse engineer the hidden wealth building formula that made those past biotech winning stocks explode.
As a result, my Profit Lab System automatically rejects 99 out of 100 biotech stocks because they simply do not fit the money pattern that has proven profitable. Over the years, we’ve fine-tuned our system to identify only those stocks that will double your money or more.
This is how my Profit Lab System finds rising stars — unknown stocks that are set to explode (and do) — all because they contain the same combination of double-your-money breakthroughs in biotechnology, sales, and profit potential that you’ll find in the world’s most profitable biotech stocks.
Imagine what it would feel like to own the next KERYX, ALFACELL, or SYMBOLLON — before these companies turned a $5,000 investment into $92,353, $276,944, and $500,000, respectively.
With my Profit Lab System guiding your investments, that’s exactly how you could feel from this point forward. And that’s a feeling you can’t beat.
Black and White Proof You Can Use My
System to Join the Super Rich
Take ALFACELL and SYMBOLLON, for example.
They offer you a crystal-clear example of how my Profit Lab System could easily make you rich by focusing on little-known, yet BIG POTENTIAL biotech stocks that are ready to explode.
To be sure, not every one of the stocks we select will hand you 9,900% returns. But we’ll take anything that doubles our money or better.
For example:
If you invested $500 in ALFACELL, your investment would have mushroomed into $27,694. By rolling this into SYMBOLLON, you would have snowballed your $27,694 into an incredible $2,769,400 when this company’s shares blasted from 5 cents to $5.
And that’s if you had chosen to invest in just one biotech breakthrough at a time.
Had you chosen to roll just half your SYMBOLLON profits into ELAN, you would have turned your initial $500 investment in ALFACELL into a whopping $32,967,017. That, my friend, is how you get rich in biotech stocks. And why my readers continue to rave about the results we deliver.
A $5 Secret That Turns Ordinary Investors into
Multi-Millionaires
It’s no fluke biotech stocks can pile up profits 10 times faster than 9 out of 10 NASDAQ stocks. That’s because they simply have more room to grow. It’s a simple concept but it will make you rich.
Fact is: You’ll never get rich buying stocks priced at $30. Stocks priced at $30 or higher can take 10 years to double your money.
Even stocks at priced at $15 could take at least 5 years to double. Do you really want to wait that long to get rich? I think not.
Yet, a quick look at the top performing biotech stocks priced at $5 or less and you’ll see how they can double in months, if not weeks. Why?
Because biotech stocks priced at $5 or less are relatively unknown. As a result, few investors own them. Of course, once they get FDA approval everybody knows about them and their prices explode like fireworks on the 4th of July.
For example, if you invested $5,000 in BIOENVISION at $0.50 a share, you would you would have seen your stake explode to $120,000 as the FDA gave the company fast-track status for its anti-pneumonia breakthrough and its price blasted to $12.
Then there’s DYAX. Thanks to its new discovery for treating cystic fibrosis, this $1 stock soared past $15 — $7,500 invested here would have handed you a whopping $111,786.
How do you think billionaire moneymakers like Warren Buffett, John Templeton, and JP Morgan got rich? Not by buying the likes of Genentech and Amgen for $75 a share when everyone knew about them.
My Profit Lab System
Makes it Easy for You
to Get Filthy Rich in
Biotech Stocks
How? By rejecting 99 out of 100 stocks before the FDA does! That’s why our picks explode from drug approvals soon after we buy them
You could search high and low and never find a safer or more profitable way to reap enormous profits investing in biotech stocks. My Profit Lab System does everything for you, from scanning for companies with late-stage candidates that target large or underserved markets to identifying new breakthroughs with amazing potential to revolutionize the healthcare industry.
As you’ll see, my Profit Lab System eliminates companies whose science has a snowball’s chance in hell of getting FDA approval, automatically protecting us from buying worthless drug stocks.
In addition, my Profit Lab System also eliminates stocks trading well above $5, making sure that we always get in on the ground floor — and not after big run-ups.
As a result, the Profit Lab System rejects 99 out of 100 biotech stocks. Those that make our final cut have a deep product pipeline with many promising late-stage candidates, highly lucrative marketing agreements with blue-chip drug manufacturers, and most importantly, expert management with a “Barry Bonds-like” batting average for getting FDA approval.
This is how the rich get rich in biotech stocks, and how you could too.
They bought explosive up-and-coming stocks for pennies on the dollar when nobody knew these companies were even listed.
Mark my words, when you add a basketful of little-known $5 biotech stocks to your portfolio, you too will sell them for dream gains when their prices explode. No other outcome is possible.
For these reasons, my Profit Lab System not only evaluates a company’s fundamentals and product pipeline, but it also screens for secret factors nobody else looks for.
This is how we find so many ground-floor opportunities before they skyrocket, and how you could easily turn a $500 investment into thousands of dollars faster than virtually every other investing system on the planet.
My Next Five Picks Could Make
You $75,000 to $100,000 EACH
in the Next 6 Months
Grab all you can now. They’re super dirt-cheap. Nobody’s heard
of them. Each one could hand you a minimum of $12 for $1 returns.
If you want to get rich, you must own these stocks. If they’re just half as successful as ALFACELL, SYMBOLLON, or KERYX, you couldn’t live long enough to spend all the money you’ll make. From $500 to $50,000
in 11 Months!
That’s how fast you can make
money in biotech stocks
Symbollon Pharmaceuticals represents an extreme example of how fast you can get rich investing in biotech stocks. Virtually unheard of in January 2003, the stock blasted from 5 cents to $5 when research revealed positive results associated with the company’s cancer drug. Had you been lucky enough to invest $500 in this up-and-comer, you’d be sitting on a whopping $50,000.
Imagine if you had invested $5,000! You would now be sitting on life-changing gains of $495,000! Those who got in on this one when few people knew the company existed are not only smiling all the way to the bank, they probably own it!
Rake in Mammoth Profits
with the Next Symbollon
But you must hurry. This company’s anti-aging miracle could make Botox, collagen, and face lifts totally obsolete. Get in early and you’ll grab mind-blowing gains when the company gets final FDA approval.
Since the company’s anti-aging product was released in Europe, the stock has rewarded biotech investors with 200% profits. When its products hit the U.S., we expect to make at least 10 times our money. You’ll read why, in your FREE REPORT.
Each one of these barnburners has what I call the “perfect storm” of fundamental and technical indicators that have made early investors in AMGEN and GENENTECH wealthy beyond their dreams...
They could hand you $12 for $1 profits. If they hit their full potential — watch out! You could buy your own bank.
The best part is, all you have to do is call your broker and say “Buy.” We’ve done all the work, sifting through hundreds of thousands of bits of data on each stock, like a miner who sifts tons of dirt to get to the gold.
If you miss these winners, you’ll kick yourself for years. Enormous wealth is at hand. Each one of these wealth-builders is like buying a 10-pound gold bar for just pennies on the dollar.
Get All the Mouth-Watering Details in These 5 FREE BONUSES
But you must hurry! They’re all going to soar when they’re discovered.
I’m so convinced that my Profit Lab System will make you richer than your wildest dreams, I’m going to send you my entire wealth-building library FREE. This is no misprint. Each one of these five bonuses is yours, 100% absolutely FREE.
......................
